ArticleBreast cancer research and treatment2021
The WISDOM study: a new approach to screening can and should be tested.
Article in Breast cancer research and treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Artificial intelligence for risk-stratified breast cancer screening: a systematic review of evidence, clinical integration, and ethical implications in risk assessment tools.La Radiologia medica · 2026Pooled it
- ESR Essentials: screening for breast cancer - general recommendations by EUSOBI.European radiology · 2024Guideline
- Psychological impact of risk-stratified screening as part of the NHS Breast Screening Programme: multi-site non-randomised comparison of BC-Predict versus usual screening (NCT04359420).British journal of cancer · 2023Trial
- Earlier screening, better outcomes? Revisiting breast cancer screening guidelines for women in their 40s.Canadian journal of public health = Revue canadienne de sante publique · 2026Article
- Five-Year Absolute Risk-Based and Age-Based Breast Cancer Screening in the US.JAMA network open · 2026Article
- Breast cancer risk prediction with a modified BOADICEA model in Danish women.British journal of cancer · 2026Article
- Profile of the BREATHE cohort for risk-based breast screening in Singapore.Scientific reports · 2025Article
- Artificial Intelligence-Driven Personalization in Breast Cancer Screening: From Population Models to Individualized Protocols.Cancers · 2025Review
- Key stakeholders' perspectives on implementation of risk-based population breast cancer screening in Australia - "We can either get on the bus or get under it".Archives of public health = Archives belges de sante publique · 2025Article
- Emotional distress and quality of life in high and moderate penetrance germline mutations carriers diagnosed with breast cancer: a preliminary study.Medicine and pharmacy reports · 2025Article
- Perceptions of breast cancer risk after breast density notification in a population-based screening program.Breast cancer research and treatment · 2025Article
- Personalized screening based on risk and density: prevalence data from the RIBBS study.La Radiologia medica · 2025Observational
- Review
- Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study.BMC cancer · 2025Article
- A Scoping Review of Primary Breast Cancer Risk Reduction Strategies in East and Southeast Asia.Cancers · 2025Review
- Stratified/risk-based screening for colorectal cancer in the UK: an overview.Colorectal cancer · 2025Review
- The risk-based breast screening (RIBBS) study protocol: a personalized screening model for young women.La Radiologia medica · 2024Article
- Implementation considerations for risk-tailored cancer screening in the population: A scoping review.Preventive medicine · 2024Article
- Attitudes towards risk-stratified breast cancer screening: a population-based survey among 5,001 Danish women.BMC cancer · 2024Article
- Prediction of breast cancer risk for sisters of women attending screening.Journal of the National Cancer Institute · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
34529196What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.